MENU

Can Synchrony Financial (SYF) Stock Reach $84?

a savings bank

SYF
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
Oct 19, 2026

Can Synchrony Financial (SYF) Stock Reach $84?

Key Takeaways

  • The central $84 price target is the arithmetic mean of roughly a dozen recent, verified analyst price targets reviewed for this article, spanning approximately $74 to $93.
  • At a recent price near $74, reaching $84 implies a rise of roughly 13%, a relatively modest move for a financial stock.
  • Analyst opinion skews constructive but not unanimous: the broader consensus is generally characterized as "Buy" or "Moderate Buy," with several Hold ratings clustered in the low-$80s.
  • The strongest supports are expected earnings growth, stable consumer credit, strong capital returns, and an expanding partnership network.
  • The biggest risks are the proposed cap on credit card interest rates, muted receivables growth, and any renewed deterioration in consumer credit.

Analyst Price Targets and Consensus View

Synchrony Financial (SYF) is a consumer financial services company best known for private-label and co-branded credit cards, managing over $103 billion in loan receivables and roughly 70 million active accounts. For this article, I reviewed approximately a dozen current, individually attributable analyst targets from firms including Barclays, Wolfe Research, Bank of America, Goldman Sachs, Wells Fargo, TD Cowen, Morgan Stanley, UBS, BMO Capital, RBC Capital, Evercore ISI, and J.P. Morgan.

The arithmetic mean of these targets is about $84.33, which rounds to a central target of $84. The spread is meaningful: the most bullish calls sit near $93 (Barclays) and $90 (Wolfe Research), while the most cautious sit near $74 (J.P. Morgan) and $80 (RBC Capital and Evercore ISI). Independent consensus services report somewhat higher averages in the high-$80s to low-$90s, reflecting a handful of additional and higher targets; I note this for context rather than treating any single published consensus figure as the target.

The reasoning behind the differences matters more than any one number. Bullish analysts emphasize loan growth, net interest income momentum, improving credit trends, and generous buybacks. More cautious voices flag elevated consumer payment rates, "muted" receivables growth, and policy risk. Notably, BMO Capital initiated coverage at Market Perform with an $81 target in October 2026, while TD Cowen trimmed its target to $86 but kept a Buy rating. These mixed signals explain why the range is wide even though the overall posture remains positive.

Current Market Position and Path Toward the Target

With shares trading near $74 in mid-October 2026, moving to $84 requires upside of roughly 13%. By conventional standards, that is a modest requirement, well within what a single strong earnings season or a shift in sector sentiment can produce. The stock trades at a forward price-to-earnings (P/E) multiple in the high single digits — a relatively undemanding valuation for a company with steady earnings power.

The most plausible path toward the target runs through continued stabilization in consumer credit, a gradual reacceleration in loan receivables, and sustained capital returns. If delinquency and net charge-off trends keep improving and payment rates normalize, analysts may revise targets higher, supporting the share price. Conversely, the target could remain out of reach if credit turns or if regulatory headlines weigh on the entire card-issuer group.

What Could Support a Move Toward the Target

  • Earnings growth: consensus estimates point to EPS (earnings per share) rising from roughly $9.45 in 2026 toward $10.47 in 2027, a foundation for multiple expansion.
  • Credit normalization: improving delinquency and charge-off trends are a recurring theme in recent bullish research.
  • Capital returns: Synchrony's dividend and buyback program remain a key pillar of the investment case.
  • Partnerships: the company continues to expand its network, including renewing its long-running Polaris financing relationship and broadening its CareCredit healthcare financing platform.

What Could Prevent the Target From Being Reached

  • Interest-rate cap proposal: a proposed 10% cap on credit card rates is widely cited as the sector's largest policy risk, with some analysts describing it as a "high severity" threat to issuer profitability.
  • Muted loan growth: elevated consumer payment rates and slow receivables growth could keep net interest income pressured.
  • Credit deterioration: any renewed rise in late payments or charge-offs amid economic weakness would compress earnings and valuation.
  • Sector sentiment: consumer-finance coverage has been described as "flirting with bear market territory," and negative macro headlines could suppress multiples across the group.

Technical Levels and Market Structure

Shares entered 2026 having already pulled back meaningfully, and the stock has remained range-bound in the low-to-mid $70s through much of the year. The psychological $70 to $75 zone has acted as a floor in recent trading, while the low-$90s represents the upper end of the current analyst-target range and a natural overhead reference. There is no verified breakout to point to; the stock has yet to reclaim levels that would confirm a durable upward trend, which is itself a consideration for anyone watching the path toward $84.

Time Horizon and What Investors Should Monitor

Analyst price targets typically reflect a research horizon of roughly 12 months, though individual firms and analysts differ, and some targets are updated only around quarterly results. The next quarterly earnings report will be pivotal, with close attention to net interest income, loan receivables growth, the net charge-off rate, and any commentary on the proposed rate cap. Investors should also watch broader consumer credit data, Federal Reserve policy, and analyst target revisions, which have been moving in both directions and can signal shifting conviction across the group.

AI Daily Buy/Sell Signals

For traders who prefer a systematic, data-driven layer on top of fundamental research, Tickeron's AI Daily Buy/Sell Signals offer a way to track changing conditions in real time. The tool uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from evolving market conditions, technical behavior, and AI-driven analysis. Rather than replacing the analyst research described above, it is designed to help traders discover opportunities, monitor open positions, and spot shifting trends more efficiently as prices move. Exploring the AI Daily Buy/Sell Signals page can add a technical, momentum-based perspective to a fundamentally driven view like the one behind Synchrony's $84 target.

Final Assessment

Can SYF reach $84? The question is fundamentally about whether a roughly 13% move is achievable, and the evidence cuts both ways. On one side, a supportive consensus, single-digit valuation, improving credit trends, and heavy capital returns make the move plausible. On the other, a proposed rate cap, sluggish loan growth, and fragile sector sentiment give the cautious camp legitimate grounds for their lower targets. With the analyst range spanning roughly $74 to $93, the market itself is undecided on how far Synchrony can climb. The next earnings report and any legislative movement on credit card rate caps will be the clearest signals of which direction the balance tips.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
SYF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

SYF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SYF has been closely correlated with COF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if SYF jumps, then COF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYF
1D Price
Change %
SYF100%
-1.19%
COF - SYF
82%
Closely correlated
+0.87%
OMF - SYF
75%
Closely correlated
+0.32%
AXP - SYF
75%
Closely correlated
+0.61%
ALLY - SYF
74%
Closely correlated
+1.01%
BFH - SYF
74%
Closely correlated
+2.11%
More

Groups containing SYF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYF
1D Price
Change %
SYF100%
-1.19%
SYF
(8 stocks)
57%
Loosely correlated
+0.77%
Savings Banks
(54 stocks)
54%
Loosely correlated
-0.12%
Banks
(430 stocks)
30%
Poorly correlated
+1.14%